权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders

了解惰性淋巴细胞增殖性疾病的心理社会和免疫反应

基本信息

批准号：
9038558
负责人：
Kerry S Campbell
金额：
$ 66.25万
依托单位：
RESEARCH INST OF FOX CHASE CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-01-01 至 2020-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9038558
关键词：
Activated Natural Killer Cell Adverse effects Affect Affective Anxiety Appointment Arousal Biological Markers Cancer Model Cancer Patient Cell physiology Characteristics Classification Clinical Development Diagnosis Disease Disease Progression Disease model Distress Early identification Flow Cytometry Follicular Lymphoma Fright Future Health Care Costs Human Immune Immune response Immunity Immunologic Markers Immunologics Individual Individual Differences Indolent Lead Life Longitudinal Studies Lymphocyte Lymphoproliferative Disorders Malignant Neoplasms Monitor Morbidity - disease rate NK Cell Activation Natural Killer Cells Neurotic Disorders Newly Diagnosed Non-Hodgkin&apos s Lymphoma Outcome Pathway interactions Patient Monitoring Patients Personal Satisfaction Phase Phenotype Physiological Play Psychological Stress Reporting Research Risk Risk Factors Role Stress Sum Symptoms T-Cell Activation T-Lymphocyte Time Uncertainty animal data biobehavior biological adaptation to stress cancer therapy clinically relevant exhaust exhaustion experience immune function killer T cell large cell Diffuse non-Hodgkin&apos s lymphoma novel optimism patient population prognostic prospective psychologic psychosocial public health relevance receptor response standard of care stressor time interval tool tumor progression

项目摘要

DESCRIPTION (provided by applicant): In 2015, about 71,850 cases of non-Hodgkin lymphoma [NHL] will be diagnosed in the US. Approximately 35% of patients with NHL will present with indolent disease, which progresses very slowly, but is considered incurable. Because there is no survival benefit to initiating treatment immediately after diagnosis, a "watch-and- wait" [WW] approach (in which patients are monitored frequently) is the standard of care until disease-related symptoms emerge. The benefits of WW include reduced healthcare costs and avoidance of treatment-related side effects; however, many patients report elevated levels of distress and cancer-related worry during the WW phase. The uncertainty associated with the unknown trajectory of an incurable disease can be distressing and act as a powerful stressor, resulting in both psychological and physiological consequences. Notably, some individuals may be more affected by uncertain situations. Individual differences in various characteristics, such as "intolerance of uncertainty" [IU] and neuroticism, have been associated with greater stress and physiologic arousal. Over time, stress-related immune alterations may have clinical consequences for disease progression, since immune deficits are a strong risk factor for NHL. Natural killer [NK] cells, which are particularly sensitive to psychological stress, are critical i controlling NHL. In humans, lower numbers of NK cells, reduced viability of NK cells, and diminished expression of NK cell activating receptors have been associated with NHL disease progression and shorter survival, whereas stronger host immunity is associated with a more indolent disease course. T cells are also key effectors in mounting immune responses to NHL, and through the use of modern flow cytometry, their biomarker phenotypes can now provide sensitive indicators of immune function. Given the anxiety and distress associated with a WW approach, and the role of immune factors in disease progression, indolent NHL offers a unique disease model within which to examine biobehavioral pathways in an untreated cancer patient population. Thus, guided by a biobehavioral model of cancer stress, we propose to conduct a prospective, longitudinal study of 225 newly diagnosed patients with indolent NHL undergoing WW, to investigate whether poorer psychosocial functioning (as characterized by higher stress and anxiety) is associated with suppressed NK functional activity (degranulation response) and reduced expression of activating NK cell receptors, which in turn, have prognostic implications for disease progression over time. The specific aims are: Aim 1. To examine associations of psychosocial functioning (e.g., perceived stress, anxiety) with expression of NK cell and T cell activation markers and functional activity over time; Aim 2. To assess whether these immunologic markers are associated with a shorter interval of time to treatment; and Aim 3. To identify characteristics that may predict poorer outcomes over time. Study findings will have direct translational relevance, including a potential for early identification of patients at-risk or disease progression and the development of non-pharmacologic approaches for reducing morbidity in this understudied patient population.